Betterchem
Health     Drug Information     News     Portal     21CFR     Search     Site Map

 
Our server has compiled a list of research citations.

Exclusivity
Patents and exclusivity

Drug Information
Prescribing and other information

DMFs
Type 2 master files

Databases
Free access to database search

21 CFR
FDA regulations for this API

Federal Register
FR search results for this API

Drug Recalls
For Rx's using this API

FDA Approval Activities for this Drug…

Errin (Norethindrone) Tablets, 0.35 mg, Barr, ANDA 76-225 Estrostep (Norethindrone Acetate & Ethinyl Estradiol) Tablets, Parke-Davis Pharmaceutical Research NDA 21-276 7/13/01 11/6/01 11/6/01 12/12/01 Estrostep (Norethindrone Acetate/ Ethinyl Estradiol) Tablets, Parke-Davis Pharmaceutical Research NDA 20-130/S07 7/01/01 4/25/03 Estrostep (Norethindrone Acetate/ Ethinyl Estradiol) Tablets, Pfizer, NDA 20-130/S009 6/14/02 6/17/02 Estrostep (Norethindrone Acetate & Ethinyl Estradiol) Tablets, Parke-Davis Pharmaceutical Research NDA 20-130/S003 Femhrt (norethindrone acetate and ethinyl estradiol), tablets, [patient information] Parke-Davis NDA 21-065 Microgestin Fe 1/20 Tablets (Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1.0 mg/0.02 mg, Ferrous Fumarate Tablets, 75mg),Rx Watson, ANDA 75-647 2/5/01 3/5/01 Microgestin Fe 1.5/30 Tablets (Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1.5 mg and 0.03 mg, and Ferrous Fumarate Tablets, 75mg),Rx Watson, ANDA 75-548 Norethindrone Acetate Tablets USP, 5 mg, Barr, ANDA 75-951 Nortrel 7/7/7 (Norethindrone and Ethinyl Estradiol) Tablets USP, 0.5mg/0.035 mg, 0.75 mg/0.035 mg, and 1 mg/0.0.35 mg, Barr, ANDA 75-478 8/30/02 Nortrel 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP), 0.5mg/0.035 mg, 0.75 mg/0.035 mg, and 1 mg/0.0.35 mg, Barr, ANDA 75-478 Ortho Micronor (Norethindrone) Tablets, Johnson & Johnson NDA 16-954/S92 Ovcon 35 (norethindrone and ethinyl estradiol) tablets, chewable, Warner Chilcott Femhrt (norethindrone acetate/ethinyl estradiol), Tablets, Galen (Chemicals) Limited CombiPatch (estradiol/norethindrone acetate) transdermal system, Novartis Pharmaceuticals | Aranelle (Norethindrone & Ethinyl Estradiol) Tablets, Barr Laboratories, Approval | Nevis (Norethindrone Acetate & Ethinyl Estradiol) Tablets, Barr Labs, Tentative Approval | Combipatch (estradiol/norethindrone acetate transdermal system), Novartis, Labeling Revision | Femhrt (norethindrone acetate/ethinyl estradiol tablets), Warner Chilcott Company, New Dosage Regimen | Norethindrone Acetate & Ethinyl Estradiol Tablets & Ferrous Fumate Tablets, Andrx Pharma, Approval | Norethindrone Acetate and Ethinyl Estradiol Tablets & Ferrous Fumarate Tablets, Andrx Pharma, Approval | Nor-QD (norethindrone) Tablets, Watson Labs, Labeling Revision | Combipatch (estradiol/norethindrone acetate transdermal system), Novartis Pharma, Labeling Revision | Loestrin 24 Fe (norethindrone acetate/ethinyl estradiol and ferrous fumarate) Tablets, Approval | Activella (estradiol/norethindrone acetate) tablets, Novo Nordisk, Labeling Revision & New Dosage | Ovcon 35 (norethindrone/ethinyl estradiol) Chewable Tablet, Warner Chilcott, Control Suppl.

Check the most up-to-date list of FDA Approvals.


 

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline

© 2008 Betterchem.com